Qube Research & Technologies LTD Cytokinetics Inc Transaction History

Qube Research & Technologies LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $1.37 Million - $2.14 Million	-28,562 Reduced 95.12%	1,466 $79,000
Q1 2024 May 14, 2024	SELL	$63.75 - $108.06 $20.4 Million - $34.6 Million	-320,507 Reduced 91.43%	30,028 $2.11 Million
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $9.16 Million - $28.5 Million	340,827 Added 3510.78%	350,535 $29.3 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $2.53 Million - $3.14 Million	-85,848 Reduced 89.84%	9,708 $285,000
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $226,448 - $282,886	-6,942 Reduced 6.77%	95,556 $3.12 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $3.42 Million - $4.69 Million	102,498 New	102,498 $3.61 Million
Q4 2021 Feb 01, 2022	SELL	$34.35 - $46.38 $425,046 - $573,906	-12,374 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $229,413 - $442,246	12,374 New	12,374 $442,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $209,794 - $393,330	-13,748 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$20.58 - $28.96 $207,672 - $292,235	-10,091 Reduced 42.33%	13,748 $298,000
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $265,804 - $587,392	23,839 New	23,839 $562,000

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.44B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.